Stengone Carmine N. bought CTNM
June 30, 2026 · Form 4 insider transaction
Stengone Carmine N. bought 2,500 shares of Contineum Therapeutics, Inc. at $1.26 per share, a transaction worth $3.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$1.26
Total value
$3.1K
InsiderStengone Carmine N.
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after27,217
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.